Activities of New Beta-Lactam Antibiotics Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis
AUTOR(ES)
Prince, Alice S.
RESUMO
The in vitro activities of gentamicin, tobramycin, amikacin, azlocillin, carbenicillin, mezlocillin, piperacillin, ticarcillin, cefotaxime, ceftizoxime, cefoperazone, cefsulodin, moxalactam, ceftazidime, ceftriaxone, and N-formimidoyl thienamycin were measured against 62 isolates of Pseudomonas aeruginosa obtained from patients with cystic fibrosis. Ceftazidime and N-formimidoyl thienamycin were the most active of these agents.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181741Documentos Relacionados
- Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.
- Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.
- Bactericidal activities of new beta-lactam antibiotics against Bacteroides fragilis.
- In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa.
- In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.
